Bempedoic Acid 180 MG Oral Tablet

DRUG4 trials

Sponsors

Esperion Therapeutics, Inc., Sohaib Ashraf, Kenneth Hallows, Punjab Institute of Cardology

Conditions

ADPKD (Autosomal Dominant Polycystic Kidney Disease)Acute Coronary Syndromes (ACS)CardiovascularHealthy Lactating Women

Phase 2

Bempedoic Acid Therapy for Polycystic Kidney Disease

Not yet recruitingNCT07282821

Kenneth HallowsADPKD (Autosomal Dominant Polycystic Kidney Disease)

Start: 2026-02-01End: 2029-08-01Target: 120Updated: 2025-12-17

Phase 3

Bempedoic Acid Versus Statins in Primary-Prevention Patients With Suboptimal Statin Adherence: Effects on LDL-C Reduction and Tolerability

Not yet recruitingNCT07239414

Sohaib AshrafCardiovascular

Start: 2025-11-10End: 2027-02-21Target: 690Updated: 2025-11-20

Phase 4

Milk-Only Lactation Study to Evaluate the Concentration of Bempedoic Acid and Bempedoic Acid/Ezetimibe Fixed Combination Drug Product (FCDP) in the Breast Milk of Healthy Lactating Women

CompletedNCT06021951

Esperion Therapeutics, Inc.Healthy Lactating Women

Start: 2023-08-04End: 2024-03-22Updated: 2025-04-11

Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary Syndrome

Not yet recruitingNCT07508254

Punjab Institute of CardologyAcute Coronary Syndromes (ACS)

Start: 2026-05-01End: 2026-10-31Target: 120Updated: 2026-04-02